ARMMY PICCA/iStock via Getty Images Poseida Therapeutics (NASDAQ:PSTX) is expected to release results from the phase 1 study using P-BCMA-ALLO1 for the treatment of patients with relapsed or refractory multiple myeloma [r/r MM] on April 8th, 2024 12:30 p.m. PT at the American Association for Cancer Research [AACR] Annual Meeting in San Diego. Why should…
Yuichiro Chino/Moment via Getty Images In my most recent article on managed futures (“MF”) funds, I compared the KFA Mount Lucas Index Strategy ETF (KMLM) with the iMGP DBi Managed Futures Strategy ETF (DBMF), and the WisdomTree Managed Futures Strategy Fund ETF (WTMF) and suggested KMLM was my favorite of the three. However, users highlighted…
franckreporter Investment briefing With the global risk appetite now showing signs of imminent recovery based on recent market trends, there is potential scope to add beta back into equity portfolios in our estimation. The consumer discretionary sector has led the way along with communications services and utilities so far in Q4 2023 earnings growth for…
bjdlzx Like any other “trend” or noteworthy industry activity, there is a tendency for “all the players” to head in the same direction. But shareholders are paying management to find a deal or a low-cost way that the main crowd does not find. Crescent Energy (NYSE:CRGY) is a major consolidator that does not follow the…